2018 Pre-Filled Syringes Forum

Download Program

Strategic Development, Safety & Regulatory Compliance, and Commercialization of Pre-Filled Syringes

With the Pre-Filled Syringes market expected to top $16 billion dollars by 2021, the industry is looking for next generation materials, technologies and production strategies to streamline commercialization and to adapt quickly to a changing regulatory environment. Pharma Ed Resources, an industry leader since 2004 in delivering market-driven research on PFS, is proud to announce its 2018 Pre-Filled Syringes Forum. Pharma Ed brings together top scientists, regulatory experts and innovators to share best practices and the latest research in this field, enabling you to maximize your organization’s leverage in this dynamic and growing market.

Featuring Representation From:

• Biogen
• Genentech
• Allergan
• Bristol-Myers Squibb
• GSK
• Sanofi Genzyme
• Janssen R&D
• Merck
• Shire
• Ompi
• MedImmune
• Ypsomed
• rapID
• Exova
• PTI
• Toxikon
• Datwyler
• Bosch
• Airvac
• Eakins & Associates
• West
• Harro Holfinger

Including Special Coverage On:

• Critical Issues—Examining the Regulatory Environment for PreFilled Syringes & Combination Drug-Delivery Systems
• Quality and Regulatory Affairs Best Practices for External Partnerships in Combination Product Development
• Ophthalmic Injections: The Manufacturer, Regulator, Physician, and Patient Ecosystem
• Applying Quality-by-Design Principles to the Development of Pre-filled Syringes
• Filling of High-Concentration mAb Formulations into Pre-filled Syringes – Understanding Nozzle Clogging and Filling Accuracy
• Syringe Siliconization and its Role in Protein Aggregation
• Pre-filled syringes(PFS) and container closure integrity testing (CCIT)
• Challenges and Opportunities for Development of Stability Program for Combination Products
• Devices for Self-Injection: Advantages of the Platform Approach
• Challenges Associated with PFS Combination Product Development for Ophthalmic Applications
• Strategic and Technical Considerations for PFS and Autoinjector Development for Biologics
• And Much More!